Glycosylphosphatidylinositol- Anchored Immunoglobulin Superfamily Cell Adhesion Molecules and Their Role in Neuronal Development and Synapse Regulation

Total Page:16

File Type:pdf, Size:1020Kb

Glycosylphosphatidylinositol- Anchored Immunoglobulin Superfamily Cell Adhesion Molecules and Their Role in Neuronal Development and Synapse Regulation fnmol-10-00378 November 13, 2017 Time: 16:57 # 1 REVIEW published: 15 November 2017 doi: 10.3389/fnmol.2017.00378 Glycosylphosphatidylinositol- Anchored Immunoglobulin Superfamily Cell Adhesion Molecules and Their Role in Neuronal Development and Synapse Regulation Rui P. A. Tan, Iryna Leshchyns’ka and Vladimir Sytnyk* School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW, Australia Immunoglobulin superfamily (IgSF) cell adhesion molecules (CAMs) are cell surface glycoproteins that not only mediate interactions between neurons but also between neurons and other cells in the nervous system. While typical IgSF CAMs are transmembrane molecules, this superfamily also includes CAMs, which do not possess transmembrane and intracellular domains and are instead attached to the plasma membrane via a glycosylphosphatidylinositol (GPI) anchor. In this review, we focus Edited by: on the role GPI-anchored IgSF CAMs have as signal transducers and ligands in Jaewon Ko, Daegu Gyeongbuk Institute of neurons, and discuss their functions in regulation of neuronal development, synapse Science and Technology (DGIST), formation, synaptic plasticity, learning, and behavior. We also review the links between South Korea GPI-anchored IgSF CAMs and brain disorders. Reviewed by: Davide Comoletti, Keywords: cell adhesion molecules, neuronal, GPI anchor, synapses, neurite outgrowth, synaptic plasticity Rutgers University, The State (LTP/LTD), learning and memory University of New Jersey, United States Valentin Stein, INTRODUCTION University of Bonn, Germany *Correspondence: Cell adhesion molecules (CAMs) are expressed across all cell types. In the nervous system, multiple Vladimir Sytnyk families of CAMs are expressed in neurons, including integrins, cadherins, selectins, neuroligins, [email protected] neurexins, and the immunoglobulin superfamily (IgSF) of CAMs (Brümmendorf and Rathjen, 1993; Chothia and Jones, 1997; Buckley et al., 1998; Südhof, 2008; Sytnyk et al., 2017). These Received: 14 September 2017 Accepted: 30 October 2017 molecules play numerous roles in the developing and mature nervous system by regulating growth Published: 15 November 2017 and branching of neurites, navigating growing axons and dendrites to the appropriate targets, regulating formation and maturation of synaptic contacts, and maintaining synapse function and Citation: Tan RPA, Leshchyns’ka I and plasticity during learning and memory formation. Sytnyk V (2017) Typically, and for some families exclusively, CAMs are transmembrane proteins. While the Glycosylphosphatidylinositol- extracellular domains of these molecules mediate interactions not only between neurons but Anchored Immunoglobulin also between neurons and other cells by interacting with the same molecules or other types of Superfamily Cell Adhesion Molecules molecules either on the membranes of other cells or in the extracellular matrix, the intracellular and Their Role in Neuronal domains are involved in interactions with the cytoskeleton and signal transduction (Leshchyns’ka Development and Synapse Regulation. and Sytnyk, 2016). However, CAMs can also be anchored to the plasma membranes via a Front. Mol. Neurosci. 10:378. glycosylphosphatidylinositol (GPI) anchor, with the highest number of the GPI-anchored CAMs doi: 10.3389/fnmol.2017.00378 within the IgSF (Figure 1 and Table 1). Although these proteins do not possess intracellular Frontiers in Molecular Neuroscience| www.frontiersin.org 1 November 2017| Volume 10| Article 378 fnmol-10-00378 November 13, 2017 Time: 16:57 # 2 Tan et al. GPI-Anchored IgSF CAMs in Neurons domains, their functions are not limited to mediating cell Ectodomains of IgSF CAMs may also contain fibronectin adhesion only. In this review, we summarize the role GPI- type III repeats, which are also present in ectodomains of anchored IgSF CAMs have as signal transducers, ligands, synapse some GPI-anchored IgSF CAMs, such as contactin-1, -2, -3 formation regulators, as well as their role in synaptic plasticity (Figures 1, 2). and brain disorders. In the human and murine genomes, genes coding for GPI-anchored IgSF CAMs include NEGR1, opioid-binding cell GPI-Anchored IgSF CAMs and Their adhesion molecule (OBCAM), neurotrimin (Ntm), limbic system- Homophilic and Heterophilic Interactions associated membrane protein (LAMP), IgLON5, contactin-1, -2, Immunoglobulin superfamily CAMs are identified by the -3, -4, -5, -6, Thy-1, and carcinoembryonic antigen-related cell presence of immunoglobulin (Ig)-like domains in their adhesion molecule (CEACAM)-5, -6, -7, and -8 (Williams and ectodomains. There are several types of Ig domains present Gagnon, 1982; Oikawa et al., 1987; Yoshihara et al., 1994, 1995; in IgSF CAMs including C2-, V-, and I-type (Williams and Hachisuka et al., 1996; Ogawa et al., 1996; Funatsu et al., 1999; Barclay, 1988; Harpaz and Chothia, 1994). The V-type is Itoh et al., 2008; Sabater et al., 2016)(Table 1 and Figure 1). similar to the variable V-domain in Igs, whereas the C2 type OBCAM, Ntm, LAMP, NEGR1, and IgLON5 constitute the is similar to C1-domains in Igs (Barclay, 2003). The I-type IgLON family (Yamada et al., 2007; Hashimoto et al., 2009; Sanz (I for intermediate) shares similarities with C1- and V-type et al., 2015). In addition, short isoforms of some transmembrane domains and was initially identified in Telokin, an intracellular IgSF CAMs, such as the shortest isoform of the neural cell smooth muscle protein (Harpaz and Chothia, 1994). GPI- adhesion molecule (NCAM) with the molecular weight 120 kDa anchored IgSF CAMs differ in the numbers of V-, C2-, or (NCAM120), are also GPI-anchored (Hemperly et al., 1986). I-type Ig domains present in their ectodomains. For example, Glycosylphosphatidylinositol-anchoring of proteins to the only one V-type Ig domain is present in Thy-1, while there plasma membranes is a highly conserved post-translational are three C2-type Ig domains present in neuronal growth modification across all eukaryotes (Fujita and Kinoshita, 2012). regulator 1 (NEGR1), and six C2-type domains present in The GPI anchor is a complex structure consisting of a contactin-1, -2, -3 (Ranscht, 1988; Williams and Barclay, 1988; phosphoethanolamine linker, glycan core, and phospholipid Brümmendorf et al., 1989; Zuellig et al., 1992; Figure 1). The tail. Structural variations of the anchor are possible by the first four Ig domains of contactin-2 have also been classified as modification of phosphoinositol, glucosamine, and mannose I-type Ig domains in some studies (Harpaz and Chothia, 1994; residues within the glycan core (Paulick and Bertozzi, 2008; Freigang et al., 2000). All Ig domains of the IgSF CAMs have Fujita and Kinoshita, 2012). Application of phosphatidylinositol- a core of two b-sheets facing each other and stabilized by an specific phospholipase C (PI-PLC), an enzyme capable of cleaving intra-chain disulfide bridge (Chothia et al., 1998; Figure 2). the GPI anchor, induces removal of GPI-anchored IgSF CAMs FIGURE 1 | Examples of the GPI-anchored IgSF CAMs. Structural domains and putative glycosylation sites in the GPI-anchored IgSF CAMs are represented according to the Uniprot database. SS, disulfide bridges present in Ig domains. Frontiers in Molecular Neuroscience| www.frontiersin.org 2 November 2017| Volume 10| Article 378 fnmol-10-00378 November 13, 2017 Time: 16:57 # 3 Tan et al. GPI-Anchored IgSF CAMs in Neurons from the cell surface, indicating that the GPI anchor is critical GPI-Anchored IgSF CAMs As Functional for the attachment of these proteins to the cellular membranes Receptors (Sanz et al., 2015). The complexity of the GPI anchor, however, The role for IgSF CAMs as functional receptors has been suggests that it also plays a role in other multiple functions suggested by studies analyzing effects of antibodies against these aside from membrane anchorage, including signal transduction, molecules on neurite outgrowth. Early studies using antibodies protein sorting, as well as the structure and function regulation of against Thy-1 as a growth substrate showed that Thy-1 antibodies the GPI-anchored IgSF CAMs. In particular, the GPI anchor links enhance regeneration of neurites in rat retinal ganglion neurons these molecules to membrane microdomains that are insoluble and promote survival of mouse cerebellar Purkinje cells (Leifer in cold non-ionic detergents (Varma and Mayor, 1998; Fujita et al., 1984; Messer et al., 1984). Similarly, antibodies against and Kinoshita, 2012). Such specialized membrane microdomains Thy-1 promote neurite outgrowth in rat dorsal root ganglion are referred to as lipid rafts and render GPI-anchored proteins (DRG) neurons when applied in the culture medium (Chen et al., resistant to cold non-ionic detergent extraction (Schroeder et al., 2005). Later, natural ligands of GPI-anchored IgSF CAMs have 1994; Simons and Ikonen, 1997). also been shown to induce neurite outgrowth changes. Retinal The ectodomains of GPI-anchored IgSF CAMs contain ganglion cells from Thy-1 knock-out mice show impaired neurite multiple glycosylation sites. For example, IgLON protein outgrowth over different substrates made of the proteins of family members with three Ig domains contain six or seven the extracellular matrix, including fibronectin and collagen, and N-glycosylation sites in their ectodomains (Figure 1; Pimenta Thy-1 knock-out mice demonstrate abnormal retinal formation et al., 1996; Itoh et al., 2008). NCAM120 is a prominent with thinner retinae (Simon et al., 1999). Thy-1 has also been example of a
Recommended publications
  • Association Analyses of Known Genetic Variants with Gene
    ASSOCIATION ANALYSES OF KNOWN GENETIC VARIANTS WITH GENE EXPRESSION IN BRAIN by Viktoriya Strumba A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Bioinformatics) in The University of Michigan 2009 Doctoral Committee: Professor Margit Burmeister, Chair Professor Huda Akil Professor Brian D. Athey Assistant Professor Zhaohui S. Qin Research Statistician Thomas Blackwell To Sam and Valentina Dmitriy and Elizabeth ii ACKNOWLEDGEMENTS I would like to thank my advisor Professor Margit Burmeister, who tirelessly guided me though seemingly impassable corridors of graduate work. Throughout my thesis writing period she provided sound advice, encouragement and inspiration. Leading by example, her enthusiasm and dedication have been instrumental in my path to becoming a better scientist. I also would like to thank my co-advisor Tom Blackwell. His careful prodding always kept me on my toes and looking for answers, which taught me the depth of careful statistical analysis. His diligence and dedication have been irreplaceable in most difficult of projects. I also would like to thank my other committee members: Huda Akil, Brian Athey and Steve Qin as well as David States. You did not make it easy for me, but I thank you for believing and not giving up. Huda’s eloquence in every subject matter she explained have been particularly inspiring, while both Huda’s and Brian’s valuable advice made the completion of this dissertation possible. I would also like to thank all the members of the Burmeister lab, both past and present: Sandra Villafuerte, Kristine Ito, Cindy Schoen, Karen Majczenko, Ellen Schmidt, Randi Burns, Gang Su, Nan Xiang and Ana Progovac.
    [Show full text]
  • Clinical Significance and Biological Role of L1 Cell Adhesion Molecule In
    www.nature.com/bjc ARTICLE Molecular Diagnostics Clinical significance and biological role of L1 cell adhesion molecule in gastric cancer Takashi Ichikawa1, Yoshinaga Okugawa 1, Yuji Toiyama1, Koji Tanaka1, Chengzeng Yin1, Takahito Kitajima1, Satoru Kondo1, Tadanobu Shimura1, Masaki Ohi1, Toshimitsu Araki1 and Masato Kusunoki1 BACKGROUND: L1 cell adhesion molecule (L1CAM) is highly expressed in malignant tumours and might play a pivotal role in tumour progression. METHODS: We analysed by immunohistochemistry L1CAM protein expression in formalin-fixed, paraffin-embedded specimens from 309 GC patients. We performed propensity score matching (PSM) analysis to clarify the prognostic impact of L1CAM in GC patients. We evaluated L1CAM gene expression in fresh frozen specimens from another group of 131 GC patients to establish its clinical relevance. The effects of changes in L1CAM were investigated in vitro and in vivo. RESULTS: L1CAM was mainly expressed in tumour cells of GC tissues. Elevated L1CAM expression was an independent prognostic factor for overall and disease-free survival, and an independent risk factor for distant metastasis in GC patients. PSM analysis showed that high L1CAM expression was significantly associated with poor prognosis. L1CAM gene expression using fresh frozen specimens successfully validated all of these findings in an independent cohort. Inhibition of L1CAM suppressed cell proliferation, cycle progress, invasion, migration and anoikis resistance in GC cells. Furthermore, L1CAM inhibition suppressed the growth of peritoneal
    [Show full text]
  • AVILA-DISSERTATION.Pdf
    LOGOS EX MACHINA: A REASONED APPROACH TOWARD CANCER by Andrew Avila, B. S., M. S. A Dissertation In Biological Sciences Submitted to the Graduate Faculty of Texas Tech University in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Approved Lauren Gollahon Chairperson of the Committee Rich Strauss Sean Rice Boyd Butler Richard Watson Peggy Gordon Miller Dean of the Graduate School May, 2012 c 2012, Andrew Avila Texas Tech University, Andrew Avila, May 2012 ACKNOWLEDGEMENTS I wish to acknowledge the incredible support given to me by my major adviser, Dr. Lauren Gollahon. Without your guidance surely I would not have made it as far as I have. Furthermore, the intellectual exchange I have shared with my advisory committee these long years have propelled me to new heights of inquiry I had not dreamed of even in the most lucid of my imaginings. That their continual intellectual challenges have provoked and evoked a subtle sense of natural wisdom is an ode to their efficacy in guiding the aspirant to the well of knowledge. For this initiation into the mysteries of nature I cannot thank my advisory committee enough. I also wish to thank the Vice President of Research for the fellowship which sustained the initial couple years of my residency at Texas Tech. Furthermore, my appreciation of the support provided to me by the Biology Department, financial and otherwise, cannot be understated. Finally, I also wish to acknowledge the individuals working at the High Performance Computing Center, without your tireless support in maintaining the cluster I would have not have completed the sheer amount of research that I have.
    [Show full text]
  • L1 Induces Colon Cancer Metastasis but Not EMT and CSC Markers
    Author Manuscript Published OnlineFirst on December 1, 2010; DOI: 10.1158/1541-7786.MCR-10-0406 Author manuscripts havePublished been peer reviewed OnlineFirst and accepted on December for publication 1, 2010but have not yet been edited. L1 induces colon cancer metastasis but not EMT and CSC markers L1-mediated Colon Cancer Cell Metastasis does not Require Changes in EMT and Cancer Stem Cell Markers Nancy Gavert1, Alessia Vivanti1, John Hazin1, Thomas Brabletz2, and Avri Ben-Ze’ev1 1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel 2Department of Visceral Surgery, University of Freiburg, Hugstetter Str 55, Freiburg, 79095, Germany Running title: L1 induces colon cancer metastasis but not EMT and CSC markers Key words: L1, colon cancer, metastasis, EMT, CSC Corresponding author: Avri Ben-Ze’ev Tel: (972)-8-9342422 Fax: (972)-8-9465261 E-mail: [email protected] Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Copyright © 2010 American Association for Cancer Research Downloaded from mcr.aacrjournals.org on October 1, 2021. © 2010 American Association for Cancer Research. Author Manuscript Published OnlineFirst on December 1, 2010; DOI: 10.1158/1541-7786.MCR-10-0406 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. L1 induces colon cancer metastasis but not EMT and CSC markers Abstract Aberrant activation of WNT/β-catenin signaling is common in most sporadic and inherited colorectal cancer (CRC) cells leading to elevated β-catenin-TCF transactivation. We previously identified the neural cell adhesion molecule L1 as a target gene of β-catenin- TCF in CRC cells.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Origins and Functional Impact of Copy Number Variation in the Human Genome
    doi:10.1038/nature08516 ARTICLES Origins and functional impact of copy number variation in the human genome Donald F. Conrad1*, Dalila Pinto2*, Richard Redon1,3, Lars Feuk2,4, Omer Gokcumen5, Yujun Zhang1, Jan Aerts1, T. Daniel Andrews1, Chris Barnes1, Peter Campbell1, Tomas Fitzgerald1, Min Hu1, Chun Hwa Ihm5, Kati Kristiansson1, Daniel G. MacArthur1, Jeffrey R. MacDonald2, Ifejinelo Onyiah1, Andy Wing Chun Pang2, Sam Robson1, Kathy Stirrups1, Armand Valsesia1, Klaudia Walter1, John Wei2, Wellcome Trust Case Control Consortium{, Chris Tyler-Smith1, Nigel P. Carter1, Charles Lee5, Stephen W. Scherer2,6 & Matthew E. Hurles1 Structural variations of DNA greater than 1 kilobase in size account for most bases that vary among human genomes, but are still relatively under-ascertained. Here we use tiling oligonucleotide microarrays, comprising 42 million probes, to generate a comprehensive map of 11,700 copy number variations (CNVs) greater than 443 base pairs, of which most (8,599) have been validated independently. For 4,978 of these CNVs, we generated reference genotypes from 450 individuals of European, African or East Asian ancestry. The predominant mutational mechanisms differ among CNV size classes. Retrotransposition has duplicated and inserted some coding and non-coding DNA segments randomly around the genome. Furthermore, by correlation with known trait-associated single nucleotide polymorphisms (SNPs), we identified 30 loci with CNVs that are candidates for influencing disease susceptibility. Despite this, having assessed the completeness of our map and the patterns of linkage disequilibrium between CNVs and SNPs, we conclude that, for complex traits, the heritability void left by genome-wide association studies will not be accounted for by common CNVs.
    [Show full text]
  • Learning from Cadherin Structures and Sequences: Affinity Determinants and Protein Architecture
    Learning from cadherin structures and sequences: affinity determinants and protein architecture Klára Fels ıvályi Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2014 © 2014 Klara Felsovalyi All rights reserved ABSTRACT Learning from cadherin structures and sequences: affinity determinants and protein architecture Klara Felsovalyi Cadherins are a family of cell-surface proteins mediating adhesion that are important in development and maintenance of tissues. The family is defined by the repeating cadherin domain (EC) in their extracellular region, but they are diverse in terms of protein size, architecture and cellular function. The best-understood subfamily is the type I classical cadherins, which are found in vertebrates and have five EC domains. Among the five different type I classical cadherins, the binding interactions are highly specific in their homo- and heterophilic binding affinities, though their sequences are very similar. As previously shown, E- and N-cadherins, two prototypic members of the subfamily, differ in their homophilic K D by about an order of magnitude, while their heterophilic affinity is intermediate. To examine the source of the binding affinity differences among type I cadherins, we used crystal structures, analytical ultracentrifugation (AUC), surface plasmon resonance (SPR), and electron paramagnetic resonance (EPR) studies. Phylogenetic analysis and binding affinity behavior show that the type I cadherins can be further divided into two subgroups, with E- and N-cadherin representing each. In addition to the affinity differences in their wild-type binding through the strand-swapped interface, a second interface also shows an affinity difference between E- and N-cadherin.
    [Show full text]
  • L1 Cell Adhesion Molecule in Cancer, a Systematic Review on Domain-Specific Functions
    International Journal of Molecular Sciences Review L1 Cell Adhesion Molecule in Cancer, a Systematic Review on Domain-Specific Functions Miriam van der Maten 1,2, Casper Reijnen 1,3, Johanna M.A. Pijnenborg 1,* and Mirjam M. Zegers 2,* 1 Department of Obstetrics and Gynaecology, Radboud university medical center, 6525 GA Nijmegen, The Netherlands 2 Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, 6525 GA Nijmegen, The Netherlands 3 Department of Obstetrics and Gynaecology, Canisius-Wilhelmina Hospital, 6532 SZ Nijmegen, The Netherlands * Correspondence: [email protected] (J.M.A.P); [email protected] (M.M.Z.) Received: 24 June 2019; Accepted: 23 August 2019; Published: 26 August 2019 Abstract: L1 cell adhesion molecule (L1CAM) is a glycoprotein involved in cancer development and is associated with metastases and poor prognosis. Cellular processing of L1CAM results in expression of either full-length or cleaved forms of the protein. The different forms of L1CAM may localize at the plasma membrane as a transmembrane protein, or in the intra- or extracellular environment as cleaved or exosomal forms. Here, we systematically analyze available literature that directly relates to L1CAM domains and associated signaling pathways in cancer. Specifically, we chart its domain-specific functions in relation to cancer progression, and outline pre-clinical assays used to assess L1CAM. It is found that full-length L1CAM has both intracellular and extracellular targets, including interactions with integrins, and linkage with ezrin. Cellular processing leading to proteolytic cleavage and/or exosome formation results in extracellular soluble forms of L1CAM that may act through similar mechanisms as compared to full-length L1CAM, such as integrin-dependent signals, but also through distinct mechanisms.
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • Areca Catechu-(Betel-Nut)-Induced Whole Transcriptome Changes Associated With
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.03.233932; this version posted August 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Areca catechu-(Betel-nut)-induced whole transcriptome changes associated with 2 diabetes, obesity and metabolic syndrome in a human monocyte cell line 3 4 Short title: Betel-nut induced whole transcriptome changes 5 6 7 Shirleny Cardoso1¶ , B. William Ogunkolade1¶, Rob Lowe2, Emanuel Savage3, Charles A 8 Mein3, Barbara J Boucher1, Graham A Hitman1* 9 10 11 1Centre for Genomics and Child Health, Blizard Institute, Barts and the London School of 12 Medicine and Dentistry, Queen Mary University of London, United Kingdom 13 14 2Omnigen Biodata Ltd, Cambridge, United Kingdom 15 16 3Barts and The London Genome Centre, Blizard Institute, Queen Mary University of London, 17 United Kingdom 18 19 * Corresponding author 20 Email: [email protected] 21 22 ¶These authors contributed equally to the work 23 24 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.03.233932; this version posted August 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 25 Abstract 26 Betel-nut consumption is the fourth most common addictive habit globally and there is good 27 evidence to link it with obesity, type 2 diabetes and the metabolic syndrome.
    [Show full text]
  • GWAS) Focusing on Patients with Mood Or Anxiety Disorders and Co-Occurring Alcohol-Use Disorders
    diagnostics Review Genetic Basis of Dual Diagnosis: A Review of Genome-Wide Association Studies (GWAS) Focusing on Patients with Mood or Anxiety Disorders and Co-Occurring Alcohol-Use Disorders Kaloyan Stoychev 1,* , Dancho Dilkov 2, Elahe Naghavi 3 and Zornitsa Kamburova 4 1 Department of Psychiatry, Medical University Pleven, 5800 Pleven, Bulgaria 2 Department of Psychiatry, Military Medical Academy Sofia, 1606 Sofia, Bulgaria; [email protected] 3 Medical University Pleven, 5800 Pleven, Bulgaria; [email protected] 4 Department of Medical Genetics, Medical University Pleven, 5800 Pleven, Bulgaria; [email protected] * Correspondence: [email protected]; Tel.: +359-64-886-867 Abstract: (1) Background: Comorbidity between Alcohol Use Disorders (AUD), mood, and anxiety disorders represents a significant health burden, yet its neurobiological underpinnings are elusive. The current paper reviews all genome-wide association studies conducted in the past ten years, sampling patients with AUD and co-occurring mood or anxiety disorder(s). (2) Methods: In keeping with PRISMA guidelines, we searched EMBASE, Medline/PUBMED, and PsycINFO databases (January 2010 to December 2020), including references of enrolled studies. Study selection was based on predefined criteria and data underwent a multistep revision process. (3) Results: 15 studies were included. Some of them explored dual diagnoses phenotypes directly while others employed Citation: Stoychev, K.; Dilkov, D.; correlational analysis based on polygenic risk score approach. Their results support the significant Naghavi, E.; Kamburova, Z. Genetic overlap of genetic factors involved in AUDs and mood and anxiety disorders. Comorbidity risk Basis of Dual Diagnosis: A Review of seems to be conveyed by genes engaged in neuronal development, connectivity, and signaling Genome-Wide Association Studies although the precise neuronal pathways and mechanisms remain unclear.
    [Show full text]
  • Autism Spectrum Disorders—A Genetics Review Judith H
    GENETEST REVIEW Genetics in Medicine Autism spectrum disorders—A genetics review Judith H. Miles, MD, PhD TABLE OF CONTENTS Prevalence .........................................................................................................279 Adenylosuccinate lyase deficiency ............................................................285 Clinical features................................................................................................279 Creatine deficiency syndromes..................................................................285 Core autism symptoms...................................................................................279 Smith-Lemli-Opitz syndrome.....................................................................285 Diagnostic criteria and tools..........................................................................280 Other single-gene disorders.......................................................................285 Neurologic and medical symptoms .............................................................281 Developmental syndromes of undetermined etiology..............................286 Genetics of autism...........................................................................................281 Moebius syndrome or sequence...............................................................286 Chromosomal disorders and CNVS..............................................................282 Landau-Kleffner syndrome .........................................................................286 Single-gene
    [Show full text]